Susceptibilidad Antimicrobiana in vitro de enterobacterias nosocomiales productoras de betalactamasas de espectro expandido. Cumaná, estado Sucre

• Main Authors: García José, Rodríguez Eliosmar, Carpio Carmen, Albarado Y Luzmila, Salazar Elsa, Flores F Evelin, Betancourt José, Araque Yasmina, Guzmán L Militza
• Format: Article in Journal/Newspaper
• Language: English; Spanish
• Published: Universidad del Zulia,Facultad de Medicina,Departamento de Enfermedades Infecciosas y Tropicales 2009
• Subjects: Infecciones nosocomiales; -lactamasas de espectro expandido; susceptibilidad antimicrobiana; enterobacterias; B-lactamasas de espectro expandido; Nosocomial infections; extended-spectrum beta-lactamase; antimicrobial susceptibility; enterobacteria; Arctic medicine. Tropical medicine; RC955-962; Public aspects of medicine; RA1-1270; Arctic; Salas
• Online Access: https://doaj.org/article/a1935dde1bea4169b0ec10aa29a5a98c

Abstract: In order to assess in vitro antimicrobial susceptibility for nosocomial enterobacteria ESBL producers for patients in the Autonomous University Hospital Service ‘Antonio Patricio de Alcalá,’ 27 bacterial strains were collected in the ICU, neonatology, medicine and pediatric facilities during September-November 2005. Antimicrobial susceptibility was determined by the disk diffusion method. The highest number of nosocomial infections was found in ICU and neonatology with 10 (37.03%) and 7 (25.93%) cases, respectively; 44.44% of the positive cultures were isolated from secretions. K. pneumoniae was the most frequently isolated species (51.85%), followed by Enterobacter aerogenes with 18.52%. The greatest antimicrobial resistance in the betalactam group was obtained for ceftazidime (77.77%), cefotaxime (70.37%) and cefepime (40.74%); in the aminoglycosides group, for tobramycin and gentamycin, (44.44% and 40.74%, respectively); also, chloramphenicol (70.37%), tetracycline (51.85%) and trimethoprim-sulfamethoxazole (44.44%). These results could be useful to the medical community when taking into account guidelines for treatment and risk behavior modification, which facilitate the induction of resistance, such as abuse in prescribing antibiotics and unnecessary hospitalizations. Resumen: Para evaluar la susceptibilidad antimicrobiana in vitro de enterobacterias nosocomiales productoras de BLEE en pacientes recluidos en el Servicio Autónomo Hospital Universitario “Antonio Patricio de Alcalá”, se recolectaron 27 cepas bacterianas procedentes de las salas de UCI, retén, medicina y pediatría, en el periodo septiembre-noviembre de 2005. La susceptibilidad antimicrobiana se determinó por el método de difusión del disco. El mayor número de infecciones nosocomiales se presentó en UCI y retén con 10 (37,03%) y 7 (25,93%) casos; 44,44% de cultivos positivos fueron aislados en secreciones. K. pneumoniae resultó la especie mayormente aislada (51,85%), seguida de Enterobacter aerogenes con 18,52%. La mayor resistencia ...